Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas

Neurological Research

Volumn 27, Issue 5, 2005, Pages 516-521

  Ribom, Dan ^a,b   Smits, Anja ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Neurology ^*  (Sweden)

Author keywords

Low grade glioma; Positron emission tomography; Prognosis; Time to progression

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE; METHIONINE C 11; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE; CARBON; DIAGNOSTIC AGENT; METHIONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; SEIZURE; SURVIVAL TIME; TUMOR GROWTH; TUMOR LOCALIZATION; BRAIN TUMOR; CLASSIFICATION; COMPARATIVE STUDY; DISEASE COURSE; METHODOLOGY; MIDDLE AGED; OLIGODENDROGLIA; PREDICTION AND FORECASTING; SCINTISCANNING; TIME;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; OLIGODENDROGLIA; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 85047694211     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313213X13789811969265     Document Type: Article

References (38)

1. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: An interim analysis. Int J Radiat Oncol Biol Phys 2002; 52: 316-324
2. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36: 549-556
3. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a north central cancer treatment group/radiation therapy oncology group/eastern cooperative oncology group study. J Clin Oncol 2002; 20: 2267-2276
4. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20: 2076-2084
5. Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas:-A Southwest Oncology Group study. J Neurosurg 1993; 78: 909-914
6. Pace A, Vidiri A, Galie E, et al. Temozolomide chemotherapy for progressive low-grade glioma: Clinical benefits and radiological response. Ann Oncol 2003; 14: 1722-1726
7. Quinn JA, Reardon DA, Friedman AH, et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 2003; 21: 646-651
8. Langen KJ, Muhlensiepen H, Holschbach M, et al. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: Comparison with [3H]methyl]-L-methionine. J Nucl Med 2000; 41: 1250-1255
9. Sato N, Suzuki M, Kuwata N, et al. Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999; 22: 210-214
10. Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-I-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003; 30: 868-873
11. De Witte O, Goldberg I, Wikler D, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001; 95: 746-750
12. Ribom D, Eriksson A, Hartman M, et al. Positron emission tomography 11C-methionine and survival in patients with low-grade gliomas. Cancer 2001; 92: 1541-1549
13. Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998; 39: 778-785
14. Ribom D, Engler H, Blomquist E, et al. Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas. Eur J Nucl Med 2002; 29: 632-640
15. Nuutinen J, Sonninen P, Lehikoinen P, et al. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma [In Process Citation]. Int J Radiat Oncol Biol Phys 2000; 48: 43-52
16. Karnofsky DA, Abelmann WH, Craver LF. The use of nitrogen mustards in the palliative treatment of carcinoma. With particular reference to brochogenoc carcinoma. Cancer 1948; 1: 634-656
17. Bergstrom M, Lundqvist H, Ericson K, et al. Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987; 28: 225-229
18. De Witte O, Levivier M, Violon P, et al. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 1996; 39: 470-477
19. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: A critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001; 95: 735-745
20. Berger MS, Deliganis AV, Dobbins J, et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994; 74: 1784-1791
21. Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma [see comments]. Neurology 2000; 54: 1442-1448
22. Armstrong CL, Hunter JV, Ledakis GE, et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 2002; 59: 40-48
23. Postma TJ, Klein M, Verstappen CC, et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 2002; 59: 121-123
24. Surma-aho O, Niemela M, Vilkki J, et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001; 56: 1285-1290
25. Stupp R, Janzer RC, Hegi ME, et al. Prognostic factors for low-grade gliomas. Semin Oncol 2003; 30: 23-28
26. Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled amino acids: Basic aspects and clinical applications in oncology. J Nucl Med 2001; 42: 432-445
27. Weber WA, Wester HJ, Grosu AL, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000; 27: 542-549
28. Pirotte B, Goldman S, David P, et al. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine. Acta Neurochir Suppl (Wien) 1997; 68: 133-138
29. Herholz K, Holzer T, Bauer B, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998; 50: 1316-1322
30. Roelcke U, Leenders KL. PET in neuro-oncology. J Cancer Res Clin Oncol 2001; 127: 2-8
31. Roelcke U, von Ammon K, Hausmann O, et al. Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy. J Neurol Neurosurg Psychiatry 1999; 66: 644-647
32. Voges J, Herholz K, Holzer T, et al. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: A tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 1251 seeds. Stereotact Fund Neurosurg 1997; 69: 129-135
33. Wurker M, Herholz K, Voges J, et al. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. Eur J Nucl Med 1996; 23: 583-586
34. Daumas-Duport C. Histological grading of gliomas. Curr Opin Neurol Neurosurg 1992; 5: 924-931
35. Derlon JM, Petit-Taboue MC, Chapon F, et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Neurosurgery 1997; 40: discussion 287-288
36. Bell D, Grant R, Collie D, et al. How well do radiologists diagnose intracerebral tumour histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 2002; 16: 573-577
37. Francavilla TL, Miletich RS, Di Chiro G, et al. Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 1989; 24: 1-5
38. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816-822